Home › Osteosarcoma › District of Columbia › Washington
Osteosarcoma clinical trials in Washington, DC
6 studies for Osteosarcoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's National Medical Center, Washington D.C.
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- National Institutes of Health, Bethesda · 7 mi away
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Children's National Medical Center, Washington D.C.
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- Atlanta, GA10 studies
- St. Louis, MO10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- New York City, NY6 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease29 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.